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ABSTRAK
Tujuan: mengetahui hubungan kadar vitamin D dan ekspresi CCR4 sel Treg serta kapasitas migrasi sel Treg 
pada pasien SLE di Indonesia. Metode: pengukuran kadar vitamin D, ekspresi CCR4 sel Treg dan kapasitas 
migrasi sel Treg dilakukan pada 41 pasien SLE dan 20 subjek sehat sebagai kontrol. Kadar vitamin  D diukur 
dengan teknik ELISA (Cusabio). Ekspresi CCR4 sel Treg dideteksi dengan sitometri alir (flow cytometry) dan 
kapasitas migrasi sel Treg dilakukan dalam ruang kemotaksis (chemotaxis chamber) menggunakan ligand CCR4, 
TARC, dan MDC yang selanjutnya dianalisis dengan menggunakan flow cytometry menggunakan FACS Calibur 
(Becton Dickinson). Jumlah sel Treg yang mengalami migrasi merupakan rasio jumlah sel CD4+CD25+CCR4+ 
pada ruang kemotaksis bawah dibandingkan jumlah keseluruhan sel CD4+CD25+CCR4+ sebelum migrasi 
dan dinyatakan dalam bentuk persentase. Hasil: kadar vitamin D secara bermakna ternyata lebih rendah pada 
pasien SLE dibandingkan subjek kontrol yang sehat (p=0,000). Kadar vitamin D berkaitan positif dengan 
jumlah persentase sel Treg yang bermigrasi menuju TARC (p=0,015) dan MDC (p=0,000), namun tidak 
ditemukan perbedaaan dalam hal ekspresi CCR4 sel Treg antara pasien SLE dan subjek kontrol yang sehat. 
Kesimpulan: kadar vitamin D yang rendah menyebabkan penurunan kapasitas migrasi sel Treg pada pasien 
SLE dan orang sehat. Pengaruh ini dapat terjadi lebih karena faktor lainnya dan cenderung bukan melalui 
mekanisme ekspresi CCR4.
Kata kunci: vitamin D, fungsi CCR4 sel Treg, MDC, TARC.
ABSTRACT
Aim: to determine the relationships between vitamin D and CCR4 expression on Treg, and Treg migratory 
capacity in SLE patients in Indonesia. Methods: vitamin D level assesment, CCR4 expression on Treg and 
Treg migratory capacity were  performed on 41 SLE patients and 20 healthy controls. Serum vitamin D levels 
were measured by ELISA (Cusabio). The expression of CCR4 on Treg was detected by flow cytometry and 
Treg migratory capacity was performed in chemotaxis chamber using CCR4 ligands, TARC and MDC, and 
subsequently analyzed by flow cytometry using FACS Calibur (Becton Dickinson). The number of migrated 
Treg is the ratio of CD4+CD25+CCR4+ cells number in lower chamber of chemotaxis compared to the total 
number of CD4+CD25+CCR4+ cells before migration, and stated in percentage. Results: vitamin D levels 
were significantly lower in SLE patients compared with healthy controls (p=0.000). The vitamin D levels were 
positively correlated to the percentage of migrated Treg toward TARC (p=0.015) and MDC (p=0.000), but 
there was no difference in Treg CCR4 expression between SLE patients and healthy controls. Conclusion: low 
vitamin D levels cause reduced Treg migratory capacity in SLE patients and healthy people. This influence 
occurs through other factors rather than CCR4 expression.
Key words: vitamin D, treg function CCR4, MDC, TARC.
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INTRODUCTION
Systemic lupus erythematosus (SLE) is a 
systemic autoimmune disease which occurs more 
frequently in the last decade. One mechanism 
involved in the pathogenesis of loss of tolerance 
in autoimmune disease including SLE is Treg 
dysfunctions. A decreased in Treg numbers or 
their functional deficiency seem to be associated 
with the active stage of the disease.1 The 
suppressive function of Treg on effector cells 
largely depends on their migratory capacity to the 
site of inflammation. Treg expresses chemokine 
receptors type 4 (CCR4) that respond to the 
macrophage derived chemokine (MDC/CCL22) 
and activation-regulated chemokine (TARC/
CCL17) to migrate toward APC and activated T 
cells. By this mechanism they regulate ongoing 
inflammatory responses and control these cells to 
prevent it becoming hyperactive. Treg migratory 
capacity therefore plays a critical role in the 
maintenance of self-tolerance.2 Thus, Treg are of 
considerable interest as targets for the treatment 
of autoimmune disease.3 Indeed, induction of 
Treg in experimental lupus mice can prevent the 
development of lupus manifestation.4
Vitamin D in general exerts an inhibitory 
action on the the adaptive immune reponse  by 
several mechanisms, including inhibition of 
dendritic cell (DC) maturation, Th1 activity, B cel 
maturation and differentiation and Treg function.5 
Treatment of DC with 1,25 (OH)2D can induce 
Treg development, as shown by increased 
FoxP3+ expression and Treg function by altering 
homing (migration) properties of the cells.6-7 
Hence, by impoving Treg cell function, vitamin 
D may be have beneficial effect in the heatment 
of SLE and treatment with vitamin D may 
improved patients response to immnusuppresant 
medication.8 Recent studies have reported an 
associations between vitamin D deficiency with 
the risk of SLE and disease activity of SLE.8-11
A recent study showed that in the Indonesian 
population, a country located on the equator with 
year-long sun exposure, there were a significant 
number of subjects with low levels vitamin D.12 
The clinical manifestations of Indonesian SLE 
patients are different from those of Caucasians 
origins; Indonesian SLE patients have shown 
more severe clinical manifestations, higher levels 
of anti-ds DNA antibodies, and photosensitivity.1 
These facts raise the question whether the 
severity of their clinical manifestations is affected 
by vitamin D levels result in increased Treg 
dysfunction in our patients. The aim of this study 
is to determine the associations of vitamin D, 
expression of CCR4 on Treg and Treg function 
(migratory capacity) in SLE patients in Indonesia.
METHODS
The subjects were female SLE patients 
(based on 1997 ACR criteria), had experienced 
flare, with systemic lupus erythematosus disease 
activity index (SLEDAI) score >3, and had not 
taken vitamin D supplement from Rheumato-
Immunology Clinic, Department of Internal 
Medicine, Saiful Anwar Hospital, Malang. The 
controls were healthy female matched in age, 
and body weight, and also did not take vitamin D 
supplement. This study met the ethical clearance 
by Ethics Commission of Faculty of Medicine, 
Brawijaya University. Informed consents were 
obtained from all subjects.
Isolation of Peripheral Blood Mononuclear 
Cells (PBMCs)
Four ml of fresh blood from each subject 
collected in serum separator tube was centrifuged 
in 4°C for 20 minutes. The supernatant was 
collected into fresh tubes in aliquot and stored 
in 70°C until the next process for ELISA. 
Twelve ml of heparinized blood from each 
subject was diluted 1:1 with phosphate buffer 
solution (PBS) in a canonical tube. Then, this 
mixture was layered over Ficoll® (Amersham 
Biosciences) in the ratio of 2:1 in tubes. These 
tubes were centrifuged (1000xg) in 4°C for 30 
minutes. PBMCs harvested from the interface 
between Ficoll® and plasma (the buffy coat) were 
collected into fresh tubes and washed twice with 
PBS. These PBMCs were divided into 2 tubes 
in the ratio of 1:5 for detection of CCR4 (direct/
fresh process) and Treg migratory capacity test, 
respectively.
Immunofluorecent Staining Procedure for 
CCR4 Expression on Treg
All reagents for this procedure were produced 
by Biolegend. Fresh PBMCs were re-suspended 
with 0.5 ml of cell staining buffer. 20 μl of 
FITC anti-human CD4 antibody, 20 μl of PE 
anti-human CD25 antibody and 5 μl of PerCP/
Cy5.5 anti-human CCR4 antibody were added, 
incubated at room temperature for 15-20 minutes 
in the dark, and then washed twice with 1.5 ml 
of cell staining buffer with a centrifuge at 350xg 
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for 5 minutes. The cells were re-suspended in 
0.5 ml of cell staining buffer and analyzed by 
flow cytometry. 
Treg Function
To asses the function of Treg we assayed 
the migratory capacity of Treg conducted 
in 24-well chemotaxis chambers (Costar) 
with polyvinylpyrrolidine-free polycarbonate 
membranes (5 μm pore size). The bottom chamber 
of each well was filled with 600 μl of agonist at 
the appropriate concentration (diluted in RPMI 
1640 and 0.1% BSA) and carefully overlaid 
with the polycarbonate membrane. Human 
chemokines TARC (CCL17, R&D Systems) 
and MDC (CCL22, R&D Systems) were used, 
100 and 50 ng/ml, respectively. PBMCs were 
re-suspended in RPMI 1640 medium and 0.1% 
BSA at 5x105 cells/ml, and 100 μl of the cell 
suspension was added to the top chambers. The 
chambers were incubated for 2 hours in a 5% 
CO
2
 humidified incubator at 37°C, and the cells 
migrated across the membrane into the lower 
chamber were counted with flow cytometry.
Flow Cytometry Analysis
Expression of CCR4 on Treg was the 
percentage of CD4+CD25+CCR4+ cells 
number from all CD4+CD25+ cells number. 
The number of migrated Treg is the ratio of 
CD4+CD25+CCR4+ cells number in lower 
chamber of chemotaxis compared to the total 
number of CD4+CD25+CCR4+ cells before 
migration, and stated in percentage. These analyses 
were using FACS Calibur (Becton Dickinson).
Quantitative Detection of 25(OH) Vitamin D3
25(OH)D3 was quantitatively detected by 
ELISA kit produced by Cusabio (cat. CSB-
E07900h). A hundred micro liters of standard, 
blank, or sample were added to well, covered, 
incubated for 2 hours at 37°C and the liquid 
of each well was removed without washing. A 
hundred micro liters of biotin-antibody working 
solution was added to each well and incubated 
for 1 hour at 37°C, and then washed three times. 
A hundred micro liters of HRP-avidin working 
solution was added to each well, covered, 
incubated for 1 hour at 37°C, then washed three 
times. Ninety micro liters of TMB substrate was 
added to each well, covered, incubated for 30 
minutes at 37°C in the dark. Fifty micro liters of 
stop solution was added to each well. The optical 
density of each well was determined within 30 
minutes using a microplate reader at 450 nm. 
Normal level of vitamin D is 30 ng/ml or more.
Statistical Analysis 
All results were expressed as mean±SD. The 
independent t-test was performed to compare 
variables between groups and correlations 
between two clinical parameters were evaluated 
with Pearson correlation test using SPSS 
program. The differences were significant if 
p-values were <0.05.
RESULTS
The mean age of SLE patients was not 
significantly different compared with healthy 
control subject (29.35±9.99 v.s. 32.91±5.92, 
p=0.02), with duration of illness 2-54 months. 
Most of the clinical manifestations were nephritis, 
photosensitivity, and arthritis (Table 1). Vitamin 
D levels in SLE patients were significantly lower 
than those in healthy controls (23.0±11.9 ng/mL 
v.s. 36.0±5,7 ng/mL, p=0.000). Hipovitaminosis 
D (<30 ng/ml) were observed in 29 SLE patients 
(71%) and three healthy controls (15%), whereas 
the frequency of subjects with normal levels of 
vitamin D (levels ≥30 ng/ml) was significantly 
lower compared with healthy controls (29% : 
85%, p=0.001).
Expression of CCR4 on Treg and Treg 
Migratory Capacity
The expression of CCR4 on Treg in SLE was 
not significantly different compared to healthy 
controls (49.33±17.00% v.s. 57.87±20.89%, 
p=0.230) (Figure 2B). Migratory capacity of 
Figure 1. Expression of CCR4 on Treg in healthy controls 
(A) and SLE patients (B). PBMCs were isolated from fresh 
blood and stained with immunofluorescent for Treg surface 
markers (CD4 and CD25) and its chemokine receptor marker 
(CCR4). Dots in right upper quadrants show each cells which 
was stained with CD4, CD25 and CCR4.
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CCR4+ Treg was assessed by its chemotactic 
activity using CCR4 ligands, TARC and MDC. 
The percentage of CCR4+ Treg migrated toward 
TARC in SLE tend to be lower than those of 
healthy controls (81.99±14.79% : 89.76±11.39%, 
p=0.110). The same result occurred to the 
percentage of CCR4+ Treg migrated toward 
MDC (77.15±18.60% : 80.74±17.40%, p=0.590) 
(Figure 2C). 
Vitamin D levels was positively correlated to 
Treg migratory capacity toward TARC (r=0.489, 
R2=0.239, p=0.015) (Figure 3A) and so was 
toward MDC (r=0.686, R2=0.471, p=0.000) 
(Figure 3B).
DISCUSSION
Our study showed that the majority of SLE 
patients had significantly lower serum vitamin 
D levels with 71% hypovitaminosis D, whereas 
only 15% in healthy controls. This finding was 
consistent with other study. In fact, there has 
been reported that SLE patients who continue 
to experience hypovitaminosis D after taking 
vitamin D 400-800 IU/day.13 The low levels of 
vitamin D can be either the cause or result of 
SLE, and it cannot be inferred. This has been 
suspected to lead autoimmunity due to dendritic 
cell hyperactivity, hyperactivity of effector cells 
(T cells and B cells), reduced Treg suppression 
and increased inflammatory cytokines.8-11
Table 1. Characteristics of SLE patients
Characteristics
Malar rash 70.73% Nephritis 41.50%
Discoid rash 56.10% Neurologic 
disorders
19.50%
Photosensitive 68.30% Hematologic 
disorders
78.05%
Oral ulcer 58.54% ANA positif 80.50%
Arthritis 70.73% Anti ds-DNA 
positif
73.20%
Serositis 19.50%
Figure 2. A) Comparison of vitamin D levels in SLE patients and healthy controls. B) Comparison of CCR4 
expression of Treg between SLE patients and healthy controls. C) Percentage of migrated CCR4+ Treg toward 
TARC and MDC in SLE patients compared to healthy controls.
Figure 3.  A) Correlation between vitamin D and percentage of migrated Treg toward TARC. B) Correlation 
between vitamin D and percentage of migrated Treg toward MDC.
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Previous studies have shown a decrease in 
circulating Treg number in SLE patients, and 
escepicially during the flare, their suppressive 
functions become normal in vitro. Generally, 
researchers have found a decrease in suppressive 
function of T cells, however few others have 
found the opposite; therefore the role of Treg 
cells in the pathogenesis of SLE still remains to 
be investigated further.14-15 The ability of Treg to 
suppress other cells depends on their migratory 
capability to inflammatory sites.2 Treg migration 
is regulated by specific signals emanating from 
the chemokine and integrin.16 Treg expresses 
CCR4 and CCR8 and respond to macrophage 
derived chemokine (MDC/CCL22), thymus 
activation-regulated chemokine (TARC/CCL17), 
I-309/CCL1, and vMIP-virokine I. Expression of 
CCR4 and CCR8 on Treg cells cause the cells 
to migrate toward APC and T cells, and further 
suppress the function of APC or T cells. CCL17 
and CCL22 produced by a variety of cells in 
inflammatory tissues, and recruit Treg to down 
regulate ongoing inflammatory process. CCR4 is 
the major chemokine receptor expressed by Treg.2
A number of studies suggested the existence 
of vitamins that regulate the expression of 
chemokine receptors, such as vitamin A and D, 
as well as several cytokines such as IL-12.17 In 
the rat study model of multiple sclerosis (MS) 
and experimental autoimmune encephalomyelitis 
(EAE), it was found that 1,25(OH)
2
D3 inhibited 
CCR6 expression on T cells that had been activated 
by transforming growth factor-β (TGF-β) and 
interleukin-6 (IL-6).18 Further studies conducted 
by Sigmundsdottir et al. showed that vitamin D3 
induced CCR10 expression on CD4+ T cells that 
had been activated IL-12.19
Finaly, the mechanism of immunosuppression 
requires contact between effector cells and 
Treg. Twenty percent of circulating Treg have 
CCR4, a chemokine receptor which allow Treg 
to migrate to inflammatory area to do their 
regulatory function.20 Research conducted by 
Lee et al. showed that CCR4 expression on 
Treg in SLE patients was significantly lower in 
comparison to healthy controls.20 In contrast to 
previous studies, this study shows no significant 
difference in CCR4 expression on Treg and 
their migratory capacity between SLE patients 
and healthy controls. However, when we made 
correlation from all subjects (SLE patients 
and healthy controls), there were significant 
positive correlation between vitamin D and 
Treg migratory capacity. Vitamin D affects Treg 
migratory capacity toward TARC as much as 
23.9% and toward MDC as much as 47.1%. 
These results indicated that vitamin D affects 
Treg migratory capacity through other factors 
rather than CCR4.
The current treatment for SLE is aimed at 
suppressing the immune response and excessive 
inflammation by prescribing immunosuppressive 
medications. The use of these medications has 
shown positive results in developed countries, 
however in developing countries there has been 
a financial constrain in administering these 
types of medications. This situation has led 
to the initiative of using supplement in SLE 
patients in developing countries. By improving 
Treg cells funtion, vitamin D is a good option 
to supplement immuno suppresant drugs in the 
treatment of SLE. 
CONCLUSION
Low vitamin D levels cause the reduction of 
Treg migratory capacity in SLE patients and the 
healthy controls. This influence occurs through 
factors other than CCR4 expression.
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